Pharmacy Issues: 2004 - PowerPoint PPT Presentation

1 / 41
About This Presentation
Title:

Pharmacy Issues: 2004

Description:

... associated with a drug manufacturer State Oversight Board of Pharmacy Laws, ... updates Adverse event tracking Laws & Rules Federal Oversight Different ... – PowerPoint PPT presentation

Number of Views:434
Avg rating:3.0/5.0
Slides: 42
Provided by: ElizabethC166
Category:

less

Transcript and Presenter's Notes

Title: Pharmacy Issues: 2004


1
Pharmacy Issues 2004
  • Elizabeth Curry-Galvin, DVM
  • Assistant Director, Scientific Activities
  • AVMA-Schaumburg
  • Egalvin_at_avma.org

2
Pharmacy Issues 2004
  • Topics
  • Compounding
  • Ethical Products
  • Internet Pharmacies
  • Context
  • Business
  • Legal
  • Ethical
  • Reminder
  • Allegations, No Names
  • Policy vs. Not
  • State laws and rules vary-check Colorado

3
Whats Compounding?
  • Definition
  • Simply, the preparation of custom medication for
    a particular patient (manipulation--gt unapproved
    drug)
  • Pharmacists or Veterinarians
  • Fills a niche
  • No drug approved for condition
  • Approved drug needs modification
  • Examples
  • Mixing two pre-anesthetics
  • Tablets into suspension
  • Diluting
  • Flavoring

4
Be Precise
  • Avoid generalizing when discussing compounding
  • DRUG
  • Approved drug (AMDUCA) vs. bulk drug raw drug
    ingredient or chemical (not legal)
  • VCPR
  • Custom medication prescribed for one animal vs.
    purchases outside of a VCPR
  • SCALE
  • Individual animal (compounding) vs. manufacturing
    / wholesaling (piracy)
  • ANIMAL
  • Food vs. non-food animal (different risks,
    differences in regulatory discretion)

5
2 Compounding Issues
  • Address Piracy
  • Compounding from bulk drugs is not legal
  • Need regulatory discretion from states and FDA
    when veterinarians compound medically necessary
    drugs from bulk ingredients for individual,
    non-food animals, within a VCPR because no drug
    is approved and available to adequately treat the
    patient.

6
Piracy (manufacturing unapproved drugs)
  • Piracy as distinct from traditional compounding
  • Essentially wholesaling unapproved drugs
  • Made from bulk ingredients
  • Circumvents FDA drug approval monitoring
    process
  • Mass markets products with little quality control
  • Mimic approved drug (knock-off)
  • Omeprazole, enrofloxacin, praziquantal,
    ivermectin formulations
  • Beware these are not generics!

7
Why Piracy?
  • Financial Drivers
  • Pirating firms
  • Mass production with no FDA costs
  • Veterinarians
  • Purchase drug at lower price than approved
    product, pass along or keep savings
  • Unfamiliarity
  • Lack of appreciation of differences between FDA
    approved and compounded drug
  • Lack knowledge of laws and rules
  • Mistaking compounded drugs for generic drugs
  • Assuming provider is working in patients best
    interest
  • Little enforcement visible in recent
    history..changing

8
Approved Drug Assurances
  • Safe
  • Studied under label conditions of use in target
    species
  • No contaminants (chemical, biological, toxins)
  • Effective
  • Studied under label conditions of use
  • Not sub- or super-potent (active ingredient)
  • Formulation proven successful
  • Batch to batch consistency
  • No surprises
  • You get what you paid for

9
Approved Drug Assurances
  • Scientifically proven expiration dates
  • Scientifically proven withdrawal times
  • Proper packaging assures stability
  • Label information derived from studies
  • Dose, indications, precautions, contraindications
  • Post-marketing surveillance / Label updates
  • Adverse event tracking

10
Laws Rules
  • Federal Oversight
  • Different rules for humans vs. animals!
  • FFDCA does not permit veterinarians to compound
    unapproved finished drug products from bulk drug
    substances (affirmed by two Federal Appeals Court
    decisions)
  • AMDUCA-permits compounding from approved drugs
  • FDA Compliance Policy Guide on Compounding
  • when the scope and nature of compounding raise
    the kinds of concerns normally associated with a
    drug manufacturer
  • State Oversight
  • Board of Pharmacy
  • Laws, regulations, policies, standards

11
Why is Piracy Bad?
  • Denies patient treatment with approved drug
  • Safe, effective, pure, potent, stable, GMPs
  • Exposes patient to unapproved drug
  • Contaminated, sub- or super-potent, unstable
  • Exposes parties to unnecessary liability
  • Undermines RD by drug companies
  • Veterinarians will have fewer approved drugs
  • Bulk ingredientsquality? bio-terrorism?
  • Illegal

12
AVMA Position on Compounding
  • Decision to use compounded drug driven by
    veterinarian within VCPR
  • Comply with AMDUCA and FDA Compliance Policy
    Guide on Compounding for Animals
  • Food safety concerns preclude use unless
    information exists to assure avoidance of illegal
    tissue residues

13
AVMA Position on Compounding
  • Limited to
  • Safety and efficacy of compounded drug
    demonstrated in target species,
  • Response to therapy or drug concentrations can be
    monitored, or
  • Individual patients where no other drug delivery
    is practical.
  • Precautions, counsel client, adverse reactions,
    unintended exposure

14
2 Compounding Issues
  • Address Piracy
  • Compounding from bulk drugs is not legal
  • Need regulatory discretion from states and FDA
    when veterinarians compound medically necessary
    drugs from bulk ingredients for individual,
    non-food animals, within a VCPR because no drug
    is approved and available to adequately treat the
    patient.

15
New CPG on Compounding
  • Replaced 1996 CPG (federal)
  • Emphasizes FDAs concern with compounding that
    approximates manufacturing
  • Written to facilitate enforcement
  • Did it make use of bulk drugs in compounding
    illegal?
  • No, compounding from bulk drugs has been not
    legal for years
  • However, less text on regulatory discretion..bulk

16
New CPG on Compounding
  • Less text on regulatory discretion for
    medically necessary bulk drugs
  • Includes an Appendix
  • Bulk drugs for which the FDA would not ordinarily
    object if compounded
  • Certain large animal antidotes
  • No listing of bulk drugs that are important
  • companion animal therapeutics, e.g. potassium
    bromide
  • Makes one worried if needed drug is not on the
    list
  • Renewed visibility of thorny issue
  • Business as usual?

17
Should CPG be withdrawn?
  • IACP (pharmacists) lobbying veterinarians
  • COBTA says no
  • Pro-enforcement against mfg. of unapproved drugs
  • Seeking ways to specify regulatory discretion
  • Medically necessary drugs compounded from bulk
    ingredients for individual non-food animals when
    no such approved drug exists
  • COBTA meets March 26-27

18
In-Office Use
  • In-Office Use generally recognized by state
    Pharmacy Boards
  • Upon prescription, pharmacist prepares small
    quantity for veterinarians in-office use
    (administration)
  • Facilitates timely administration of medication
    since compounded drug often mailed
  • Product labeled In-Office Use in place of
    patient name
  • Stability not definitively knownwatch shelf life
  • Not to be used as stock from which to dispense
  • Makes pharmacist a wholesaler

19
Resale of Compounded Products
  • FDA Compliance Policy Guide
  • Concern with compounding drugs for third parties
    who resell to individual patients, or offering
    compounded drugs at wholesale to other state
    licensed persons or commercial entities for
    resale.
  • Possible state Board of Pharmacy rules
  • Makes pharmacist a wholesaler
  • Dont buy pirated drugs wholesale for resale
  • Dont receive a drug compounded by a pharmacist
    for a particular patient, change the label
    dispense

20
Resale of Compounded Products
  • Question whether you can dispense In-Office Use
    compounded drug to provide timely treatment and
    bridge the time needed for the mail order drug to
    arrive (needed regulatory discretion)
  • Question whether you can prescribe, pay for, and
    receive a drug compounded by a pharmacist for a
    particular patient, then sell it (unaltered) to
    the client with a mark-up (?)

21
Reminders
  • A drug is a formulation, not just an active
    ingredient
  • Changes in formulation affect bioavailability
  • Adsorption, Distribution, Metabolism, Excretion
  • transdermals
  • Alterations in bioavailability affect treatment
    outcome

22
Reminders
  • Compounded drugs are NOT generics
  • Generics have been approved by FDA to ensure
    safety, efficacy, quality, stability, package,
    label
  • Flavored preparations can be legally compounded
    when APPROVED drugs are flavored
  • Flavoring can be an non-legal profit center for
    those who flavor bulk drugs without purchasers
    knowledge

23
State Compounding Issues
  • Arkansas Board of Pharmacy Regulation 07-02-0002
    Section (m)(5)
  • Compounding for office stock for veterinarians
    is prohibited, except for compounds to be used in
    life-threatening situations where lack of
    immediate availability of the product could
    result in patient harm and no FDA-approved
    product is commercially available.
  • ArVMA opposes, under discussion

24
State Compounding Issues
  • Texas Board of Pharmacy Proposal
  • The quantity of all compounded pharmaceuticals
    distributed to all practitioners during the
    previous 12 months pursuant to this exception
    does not exceed 5 of all prescriptions
    compounded and dispensed during the previous 12
    months. For the purposes of the exception,
    distributions to practitioners shall not be
    included in the 5 if the pharmacy receives and
    documents within 30 days of distribution, the
    name of the patient to whom the compounded
    pharmaceutical was administered.

25
Ethical Products
  • AVMA defines ethical product
  • Mfg. voluntarily limits sale to veterinarians
  • Often different name/packaging than direct to
    consumer products
  • Sold only to veterinarians as a condition of sale
    that is specified in a sales agreement or on the
    product label.

26
Ethical Products
  • AVMA Principles of Vet. Med. Ethics state
  • it is unethical for veterinarians to use or
    permit the use of their names, signatures, or
    professional status in connection with the resale
    of ethical products in a manner which violates
    those directions or conditions specified by the
    manufacturer to ensure the safe and efficacious
    use of the product.

27
Ethical Product Diversion
  • Distribution channel is manufacturers policy
  • Not government restricted distribution, e.g. Rx
  • Manufacturers responsibility to enforce its
    policycontact manufacturer with concerns
  • Legally not appropriate for associations to seek
    to influence those policies
  • Manufacturer may deny future purchases?
  • Registered as distributor?
  • Tax laws?

28
Flea and Tick
  • 40 of practices only sell flea and tick products
    to clients who have visited with the pet in the
    last year.
  • 43 practices sell to anyone
  • Source VetMedTeam.com in Veterinary Economics,
    October 2003

29
Internet Pharmacies
  • Internet pharmacies are here to stay!
  • Honor client requests for prescriptions
  • Know your rights
  • Know your responsibilities
  • Answers enforcement frequently found at state
    level
  • Do your part right Cant police everything
  • Offer clients value and convenience
  • Speak factually
  • Report complaints Complete documentation

30
AVMA Position on Internet Pharmacies
  • Drug therapy initiated by DVM within VCPR
  • Veterinarians should honor client requests to
    prescribe rather than dispense a drug
  • Client has option of filling at any pharmacy
  • Might advise clients of VIPPS pharmacies
  • Veterinarians asked by pharmacies to approve
    prescriptions they have not initiated should do
    so only if the prescription is appropriate and
    VCPR exists

31
AVMA Position on Internet Pharmacies
  • Veterinarians purview to determine medical
    criteria whereby drug is indicated, not
    pharmacist
  • Maintain written record of prescription
  • Communicate proper use, risks regardless of drug
    source
  • Use of drugs of foreign origin that lack FDA
    approval generally is not permitted

32
Current Commonly Asked DVM Questions
  • Can I charge for a prescription?
  • Do I have to provide a prescription?
  • Can I write a prescription to be used at a
    Canadian pharmacy?
  • Generic substitution?
  • Can I ignore the fax, but work with client, and
    offer a written Rx? Hospital policy?
  • What can I say about the pharmacy?
  • Can I insist the client come in for a written Rx?
  • Where do I report.?

33
Other Contacts
  • Consumer calls
  • Is it legal for my vet to
  • Agency Calls MO, MI, TN, DE responding to
    consumers allegations
  • (Per FTC It would be within its jurisdiction to
    create a regulation if consumer complaints
    indicate consumers need greater protection)
  • Jurisdictional Challenges agencies may not see
    total picture
  • Internet (human) pharmacy is exploring animal
    drugs

34
Environmental Scanning-FTC
  • 1978 FTC regulations require prescribers to
    provide eyeglass prescriptions upheld by courts
  • Dec. 6, 2003 President Bush signed Fairness to
    Contact Lens Consumers Act FTC jurisdiction
  • Congressmans wifes experience (10 years), long
    overdue, important consumers rights issue
  • Requires prescriber to provide copy of
    prescription
  • Prescriber may not charge for prescription
  • Requires prescriber to verify electronic
    prescription requests w/in 8 business hours or
    request is considered authorized
  • Consumers Union an early supporter

35
Environmental Scanning
  • Readers Digest from Consumer Reports (a
    publication of Consumers Union)
  • the veterinary care industry languishes in the
    Stone Age of consumer-protection law
  • dispute a billFluffy may be held hostage under
    state lien laws
  • vets dispense medicine, but few states require
    basic price disclosure and some dont even
    mandate written prescriptions for those keen on
    bargain hunting

36
Environmental Scanning
  • VIPPS program for veterinary pharmacies
  • To my knowledge, there are no animal-related
  • Pharmacy school classes required for graduation
  • Licensure requirements
  • CE requirements
  • American College of Veterinary Pharmacists
  • Offering certification to pharmacists who
    complete educational program on animal drugs and
    their regulation
  • Society of Veterinary Hospital Pharmacists

37
Revenue Impact of I.P. in Well-Managed Practices
  • Medicine dispensed 15 total revenue
  • 50 say volume of meds dispensed declining
  • Drop in pharmacy revenue?
  • 11 drop say 1 percent of respondents
  • 6-10 drop say 6 percent
  • lt5 drop say 38 percent
  • No change in revenue say 55
  • Source The 2003 Well-Managed Practice Study
    according to Veterinary Economics, October 2003

38
Environmental Scanning
  • Prepare for change-United Kingdom
  • Address current medicine margins
  • Identify contribution to practice income
    profits
  • Assess true costs of supplying medicines
  • Premises, heating, lighting
  • Staff time for ordering, unpacking orders, stock
    control, auditing stock and labeling, dispensing.
  • Consider difference between all medicine sales
    being lost vs.losing halfretain most of cost
    base Source Peter
    Gripper, Anval, In Practice
    publication of British Veterinary Assoc.

39
Environmental Scanning
  • Pharmacy and flea and tick products provide an
    average of just 3-4 of gross profit and
  • Pharmaceuticals have even less of an impact on
    the bottom line after accounting for operating
    expenses
  • Source Cynthia Wutchiett, Wutchiett, Tumblin
    and Assoc. in Veterinary Economics, September
    2003
  • By overcharging for medications or refusing to
    volunteer written prescriptions, the profession
    invites both regulation and loss of respect.
  • Source Linda Walker, Amboy Assoc., Veterinary
    Economics, Sept 2003

40
Enviromental Scanning
  • Charge for your time both on the farm and
    in the exam room and
  • Those fighting the Internet are modern day Don
    Quixotes. Source David M. Lane, DVM
    Newsmagazine, Jan 2004
  • Wake up call Change emphasis from selling
    products to providing services-and charging
    appropriately for services and
  • Sell at competitive prices to avoid client
    perception that everything else is overpriced
    Source Ronald Whitford, Veterinary Forum, Sept
    2003
  • Impact of pet insurance? Taxation of Internet?

41
Need for Information Exchange
  • Know your state rules and tell others!
  • Understand application of jurisdiction
  • Recycling
  • Label of dispensed products
  • Groom relationships between Bd. Of Vet Med and Bd
    of Pharm
  • Groom relationships between state VMA and state
    Boards
  • Boards know the rules
  • VMAs have constant interaction with profession
  • Report trouble! And document! Are laws/rules
    adequate?
  • Envision a preferred future
Write a Comment
User Comments (0)
About PowerShow.com